Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Dr. Chamie Interview - Quilt 3.032 study (N-803 + BCG)

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Apr 20, 2023 3:37pm

133 Views

Post# 35405957

RE:RE:RE:RE:RE:Dr. Chamie Interview - Quilt 3.032 study (N-803 + BCG)

Right Eoga,

I think TLT has a chance to prove that it can get the CRs % quite high IF they could keep on treating these NMIBC patients. Probably way more than the 16% improvement of this other study. Though with some future cancer indications TLT might not have that much % room for improving on the orig 2 treatments. :-)

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?